BCL2 interacting protein 3 pseudogene 19 (BNIP3P19)

BNIP3P19 (BCL2 interacting protein 3 pseudogene 19) is a **processed pseudogene** located on chromosome 19 (cytogenetic region 19p12). Unlike its parent gene BNIP3, which encodes a mitochondrial protein involved in apoptosis and autophagy, BNIP3P19 is classified as a noncoding genomic locus and does not produce a functional protein product[2][8][10]. There is no experimental or clinical evidence that BNIP3P19 is a druggable target, structural protein, or enzyme. While some pseudogenes can play a regulatory RNA role—such as acting as decoys for microRNAs or affecting chromatin—all credible sources indicate that BNIP3P19 does not function as a receptor, enzyme, channel, or transport protein, and has no well-established direct molecular function or role in disease[2][8][10]. Therefore, it is not recognized as a classic molecular target in pharmacology or biomedical research. Key details: - BNIP3P19 is classified in all major gene databases (GeneCards, EMBL-EBI GWAS) as a pseudogene—specifically, a processed pseudogene—with no protein product[2][8][10]. - The only molecular function for the parent BNIP3 gene involves apoptosis and autophagy; this does NOT extend to BNIP3P19[1][3][6]. - There is no evidence of disease association, therapeutic targeting, or interaction with drugs for BNIP3P19[2][10]. If you require information on the functional protein (BNIP3), please clarify, as the pseudogene BNIP3P19 is not a valid therapeutic or molecular target.

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 19BNIP3P19